JP2002514765A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514765A5
JP2002514765A5 JP2000548729A JP2000548729A JP2002514765A5 JP 2002514765 A5 JP2002514765 A5 JP 2002514765A5 JP 2000548729 A JP2000548729 A JP 2000548729A JP 2000548729 A JP2000548729 A JP 2000548729A JP 2002514765 A5 JP2002514765 A5 JP 2002514765A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000548729A
Other languages
Japanese (ja)
Other versions
JP2002514765A (ja
JP4601166B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/010200 external-priority patent/WO1999058977A1/en
Publication of JP2002514765A publication Critical patent/JP2002514765A/ja
Publication of JP2002514765A5 publication Critical patent/JP2002514765A5/ja
Application granted granted Critical
Publication of JP4601166B2 publication Critical patent/JP4601166B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000548729A 1998-05-11 1999-05-10 抗原特異的t細胞の直接的選択方法 Expired - Lifetime JP4601166B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8513698P 1998-05-11 1998-05-11
US60/085,136 1998-05-11
PCT/US1999/010200 WO1999058977A1 (en) 1998-05-11 1999-05-10 Method of direct selection of antigen-specific t cells

Publications (3)

Publication Number Publication Date
JP2002514765A JP2002514765A (ja) 2002-05-21
JP2002514765A5 true JP2002514765A5 (enExample) 2006-06-22
JP4601166B2 JP4601166B2 (ja) 2010-12-22

Family

ID=22189678

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000548729A Expired - Lifetime JP4601166B2 (ja) 1998-05-11 1999-05-10 抗原特異的t細胞の直接的選択方法

Country Status (10)

Country Link
US (2) US6576428B1 (enExample)
EP (1) EP1078263B1 (enExample)
JP (1) JP4601166B2 (enExample)
AT (1) ATE437366T1 (enExample)
AU (1) AU765085B2 (enExample)
CA (1) CA2330678C (enExample)
DE (1) DE69941150D1 (enExample)
DK (1) DK1078263T3 (enExample)
ES (1) ES2328650T3 (enExample)
WO (1) WO1999058977A1 (enExample)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166423B1 (en) 1992-10-21 2007-01-23 Miltenyi Biotec Gmbh Direct selection of cells by secretion product
CA2146974C (en) * 1992-10-21 2010-02-02 Andreas Radbruch Direct selection of cells by secretion product
CN1217698C (zh) * 1998-08-24 2005-09-07 马克西姆药品公司 应用h2受体激动剂和其它t细胞活化剂激活和保护t细胞(cd4+和cd8+)
US7807377B2 (en) * 1998-10-20 2010-10-05 Salvatore Albani Method of isolating antigen-specific T cells employing artificial antigen presenting cells
US20020044656A1 (en) * 1999-10-13 2002-04-18 Brant L. Candelore Interfacing a conditional access circuit to a digital device using input and output stream switching
US7541184B2 (en) * 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
CA2408935A1 (en) 2000-05-12 2001-11-15 Halina Offner Method of treating immune pathologies with low dose estrogen
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
JP2002365286A (ja) * 2000-11-13 2002-12-18 Kyogo Ito 細胞性免疫検出法およびその医薬への応用
US20090137416A1 (en) 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
WO2002057423A2 (en) 2001-01-16 2002-07-25 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
GB0118337D0 (en) * 2001-07-27 2001-09-19 Lonza Biologics Plc Method for selecting antibody expressing cells
EP1473564A4 (en) * 2001-09-18 2008-12-10 Greenpeptide Co Ltd METHOD FOR DETECTING CELL IMMUNITY AND ITS APPLICATION TO MEDICAMENTS
EP1539929B1 (en) * 2002-06-28 2013-04-10 Life Technologies Corporation Methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20040175373A1 (en) * 2002-06-28 2004-09-09 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
ATE328279T1 (de) * 2002-08-23 2006-06-15 Deutsches Rheuma Forschungszen Verfahren zum nachweis und zur isolierung von t- lymphozyten, die ein definiertes antigen erkennen
JP4603894B2 (ja) 2002-12-03 2010-12-22 ユセベ ファルマ ソシエテ アノニム 抗体産生細胞を同定するためのアッセイ
US20050164168A1 (en) * 2003-03-28 2005-07-28 Cullum Malford E. Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
US20040248205A1 (en) * 2003-04-16 2004-12-09 Stern Lawrence J. Major histocompatibility complex (MHC)-peptide arrays
DK1623017T3 (da) * 2003-05-08 2011-01-10 Life Technologies Corp Frembringelse og isolering af antigenspecifikke T-celler
EP1658498A1 (en) 2003-08-20 2006-05-24 Celltech R & D Limited Methods for obtaining antibodies
WO2005031357A2 (en) * 2003-09-24 2005-04-07 Ucl Biomedica Plc. Cell sample analysis
EP2253956A3 (en) * 2004-05-24 2011-07-06 Baylor Research Institute Immune response assessment method
GB0412973D0 (en) * 2004-06-10 2004-07-14 Celltech R&D Ltd Identification of antibody producing cells
EP1786465A4 (en) 2004-07-30 2009-01-21 Univ Oregon Health & Science METHODS FOR DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
WO2006050138A2 (en) * 2004-10-29 2006-05-11 Benaroya Research Institute At Virginia Mason Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use
US8227244B2 (en) * 2005-05-16 2012-07-24 The Rockefeller University Method for isolating dermal papilla cells and uses thereof
US7867765B2 (en) * 2005-12-28 2011-01-11 The General Hospital Corporation Blood cell sorting methods and systems
EP1878744A1 (en) * 2006-07-13 2008-01-16 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
US7862813B2 (en) * 2006-07-29 2011-01-04 Bjork Jr Robert Lamar Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug
CN101221171B (zh) * 2007-12-11 2011-07-20 广州益善生物技术有限公司 用于骨代谢生化标志物检测的液相芯片及其制备方法
WO2009103753A1 (en) * 2008-02-20 2009-08-27 Ablynx Nv Methods for identifying and/or sorting cells by secreted molecule and kits for performing such methods
US20110177592A1 (en) * 2008-07-11 2011-07-21 Faustman Denise L Magnetic apparatus for blood separation
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
GB0823553D0 (en) 2008-12-24 2009-01-28 Immunosolv Ltd Cell separation technique
US20120045827A1 (en) * 2009-03-09 2012-02-23 Biofactura, Inc. Separation of antigen-specific memory b cells with a conjugated biopolymer surface
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
CN102033129A (zh) * 2009-09-29 2011-04-27 上海英伯肯医学生物技术有限公司 用抗原刺激的细胞免疫反应来检测病原微生物的方法及测试笔
EP2390661B1 (en) * 2010-05-02 2015-06-24 Miltenyi Biotec GmbH An anchoring/capturing means for selecting or analyzing a CHO cell according to a product secreted by the CHO cell
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP2518504A1 (en) * 2011-04-29 2012-10-31 Miltenyi Biotec GmbH A method for the quantitative and qualitative characterization of antigen-specific T cells recognizing a specific antigen
CN111529697A (zh) 2011-05-26 2020-08-14 金纽斯生物科技投资有限责任公司 调节的免疫优势疗法
MX2014007648A (es) 2011-12-22 2015-03-19 Yeda Res & Dev Una terapia de combinacion para un injerto estable y a largo plazo usando protocolos especificos para agotamiento de celulas t/b.
US10379026B2 (en) 2012-08-29 2019-08-13 Inguran, Llc Cell processing using magnetic particles
RU2015111211A (ru) 2012-08-29 2016-10-20 Ингуран, Ллк Удаление или идентификация поврежденных или ослабленных клеток или клеточных структур при помощи магнитного воздействия
TWI675044B (zh) 2012-11-14 2019-10-21 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
CN105793411B (zh) 2013-11-16 2018-04-17 泰尔茂比司特公司 生物反应器中的细胞扩增
JP6783143B2 (ja) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド 培地の受動的補充
CN103901188B (zh) * 2014-04-11 2016-08-24 苏州浩欧博生物医药有限公司 一种吸入过敏原的化学发光定量检测试剂盒及其制备方法和检测方法
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
AU2016380262B2 (en) * 2015-12-28 2023-02-09 Novartis Ag Methods of making chimeric antigen receptor -expressing cells
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3487990A4 (en) * 2016-06-28 2020-07-29 Geneius Biotechnology, Inc. T-LYMPHOCYTE COMPOSITIONS FOR IMMUNOTHERAPY
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US20200371087A1 (en) * 2017-08-01 2020-11-26 Benaroya Research Institute At Virginia Mason Methods for identifying and separating pro-allergic specific t cells
CN110857948B (zh) * 2018-08-24 2025-01-21 武汉纳达康生物科技有限公司 H7禽流感病毒抗体磁免疫化学发光检测试剂盒及其应用
BR112021007418A2 (pt) * 2018-10-19 2021-08-10 ETH Zürich moléculas quiméricas
US20220282240A1 (en) * 2019-08-14 2022-09-08 Sanford Burnham Prebys Medical Discovery Institute Methods and devices for rare cell capture
JP2022093945A (ja) * 2020-12-14 2022-06-24 株式会社山田養蜂場本社 B細胞数増加剤
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN117433867A (zh) * 2023-10-24 2024-01-23 深圳联合医学科技有限公司 阴道微生物的荧光染色液及检测阴道微生物的方法
WO2025151270A2 (en) * 2024-01-08 2025-07-17 Board Of Regents, The University Of Texas System Microfluidic device for rapid enrichment of anti-tumor t-cells and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4452773A (en) 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
GB8408127D0 (en) 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
IL91414A0 (en) 1988-08-31 1990-04-29 Zynaxis Technologies Inc Reagents and methods for the determination of analytes
ATE114507T1 (de) 1988-12-28 1994-12-15 Stefan Miltenyi Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
US5385707A (en) 1988-12-28 1995-01-31 Stefan Miltenyi Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same
CA2146974C (en) * 1992-10-21 2010-02-02 Andreas Radbruch Direct selection of cells by secretion product
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
JPH11511746A (ja) 1995-05-25 1999-10-12 バクスター、インターナショナル、インコーポレイテッド 同種幹細胞移植後の癌の同種細胞治療
EP0852618A1 (en) 1995-07-25 1998-07-15 Celltherapy Inc. Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
EP0954601A4 (en) 1996-03-20 2004-08-18 Genzyme Corp METHOD FOR DETECTING CYTOTOXIC T-CELL EPITOPES
ES2278390T3 (es) 1996-05-23 2007-08-01 The Scripps Research Institute Sistema de presentacion de antigenos de clase ii de cmh y procedimientos de activacion de linfocitos t cd4+.
US5750356A (en) 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enExample)
BE2015C057I2 (enExample)
BE2016C007I2 (enExample)
BE2015C018I2 (enExample)
BE2014C017I2 (enExample)
BE2013C051I2 (enExample)
BE2013C020I2 (enExample)
BE2013C015I2 (enExample)
BE2013C001I2 (enExample)
JP2002501234A5 (enExample)
BE2010C011I2 (enExample)
BRPI0017527B8 (enExample)
JP2002510797A5 (enExample)
BRPI0001672A2 (enExample)
JP2002514765A5 (enExample)
JP2002507094A5 (enExample)
JP2002505896A5 (enExample)
BRPI0001542A2 (enExample)
JP2002503565A5 (enExample)
JP2002531906A5 (enExample)
JP2002518815A5 (enExample)
JP2002503032A5 (enExample)
BRPI0012675B8 (enExample)
JP2002528851A5 (enExample)
BRMU7902607U2 (enExample)